Early oncogene mRNA expression in HT-29 cells treated with the endogenous colon mitosis inhibitor pyroglutamyl-histidyl-glycine

Anticancer Res. 2002 Mar-Apr;22(2A):991-6.

Abstract

Background: The tripeptide pyroGlu-His-GlyOH (pEHG), isolated from intestinal extracts (1), suppresses growth of human colonic epithelial cells and human colorectal adenocarcinoma cells (HT-29) both in vitro and in vivo. The present study represents the first attempt to relate alterations in relevant gene expression to the effect on cell growth.

Materials and methods: Northern blot with RNA, extracted from HT-29 cells exposed to pEHG, was hybridised with c-fos and c-myc probes.

Results: c-fos gene expression was doubled in HT-29 cells after 20 minutes of incubation with pEHG and decreased to half the initial value after 2 hours. The increase at 20 minutes was concentration-dependent at a peptide concentration range from 10(-6)-10(-12) M. The expression of the oncogene c-myc showed only marginal alternations at the concentrations and times tested.

Conclusion: The colon mitosis-inhibiting peptide pEHG increases gene expression of c-fos, but not that of c-myc.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Division / drug effects
  • Cell Division / genetics
  • Gene Expression / drug effects
  • Genes, fos / drug effects*
  • Genes, myc / drug effects*
  • Growth Inhibitors / pharmacology
  • HT29 Cells / drug effects
  • HT29 Cells / metabolism
  • HT29 Cells / physiology
  • Humans
  • Oligopeptides / pharmacology*
  • Pyrrolidonecarboxylic Acid / analogs & derivatives
  • RNA, Messenger / biosynthesis*
  • RNA, Messenger / genetics

Substances

  • Antineoplastic Agents
  • Growth Inhibitors
  • Oligopeptides
  • RNA, Messenger
  • pyroglutamyl-histidyl-glycine
  • Pyrrolidonecarboxylic Acid